Panobinostat able to target and destroy triple negative breast cancer

[News]

The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.

More... (http://www.news-medical.net/news/20120521/Panobinostat-able-to-target-and-destroy-triple-negative-breast-cancer.aspx)